Tikvah Pharma Solutions
Innovating Pharmaceutical Science, Your Trusted Partner
Tikvah Pharma Solutions is a dynamic and innovative pharmaceutical company specializing in custom synthesis, process development, and analytical research.
Innovative Solutions
Our Products
Intermediates
We excel in chemistry of pharmaceutical intermediates. Therapeutics areas like Oncology, Diabetes, Antiviral, Cardiovascular, Antifungal, CNS.
Process Development
Experienced in all stages of process development from new route scouting to optimization and scale up of existing routes.
Speciality Chemicals
We provide your requirement for niche raw materials meeting higher quality specifications has escalated.
Advancing Science
Our Services
Manufacturing Services
Development of intellectual property (IP) protected synthetic routes.
Custom Synthesis
Custom Synthesis from mg to multi-kilogram scale in batch or continuous process.
Process Development
Development of GMP friendly alternative synthetic routes. Optimization of existing synthetic routes.
Leading Excellence
Our Team
Dr. Ramadas Chavakula, Ph.D.
Vice President – Research & Development (Regulated, Domestic & ROW)
Dr. Ramadas Chavakula brings over 30 years of experience in pharmaceutical research and development. He has held key positions at leading organizations including Aurobindo Pharma, Matrix (Mylan) Laboratories, Tyche Industries, Sai Life Sciences, and Neuland Laboratories.
A seasoned R&D leader, Dr. Chavakula has successfully managed end-to-end product development — from process design to regulatory approvals — and is known for his strategic vision, innovation-driven approach, and collaborative leadership.
He has published over 60 research papers in reputable journals and guided 10 PhD scholars. At Tikvah Pharma, he leads R&D initiatives aimed at advancing innovation and global excellence.
Dr. Penke Vijaya Babu, Ph.D.
Director – Advisory Research & Development
Dr. Penke Vijaya Babu brings over 17 years of expertise in pharmaceutical research, process development, and innovation. His experience spans leading roles at Piramal Pharma, Curia India, along with postdoctoral research in Israel & Poland.
Dr. Vijay has contributed to over 250 peer-reviewed publications, authored 38 research papers, holds 6 patents, and has written a book in the field of medicinal and process chemistry. He also serves as a board member, editorial reviewer, and lifetime member of more than 20 scientific organisations and professional societies.
At Tikvah Pharma, he serves as an advisory member for R&D excellence, technology advancement, and innovation in CRO & CDMO process chemistry.
Dr. Pavani Gonnabathula, Ph.D.
Advisory Board Member – Clinical Pharmacology & Regulatory Science
Dr. Pavani is a pharmacology and regulatory science expert with over eight years of experience across academia, government, and industry. Currently a PBPK/PKPD Modelling Scientist at the University of Kentucky, she leads mechanistic and population-based modelling to optimise dosing and support drug development.
Her prior fellowships at the U.S. FDA and CDC advanced Model-Informed Drug Development (MIDD) for antivirals and toxicants, complemented by early R&D experience at Aurobindo Pharma.
At Tikvah Pharma Solutions, she advises on pharmaceutical development, process optimization, and regulatory strategy—strengthening the company’s innovation, quality, and global competitiveness.
